BioOra and Cincinnati Advance CAR-T Therapy in Leukemia
Wellington, New Zealand & Cincinnati, Ohio | April 13, 2026 BioOra Limited and Cincinnati Children’s Hospital Medical Center have...
Immunotherapy
Advertisement
Allogene Therapeutics Reports Strong ALPHA3 Trial Data
South San Francisco, California | April 13, 2026 Allogene Therapeutics has announced encouraging interim results from its pivotal Phase...
AnBogen Therapeutics Showcases ABT-301 Cancer Breakthroughs
TAIPEI, Taiwan, April 13, 2026 AnBogen Therapeutics has announced that its lead investigational therapy Imofinostat (ABT-301) will be featured...
Replimune RP1 Melanoma Drug Faces FDA Rejection
Woburn, Massachusetts | April 10, 2026 Replimune Group Inc. has announced that the U.S. Food and Drug Administration (FDA)...
Allogene to Reveal ALPHA3 CAR-T Trial Data Soon
South San Francisco, California | April 10, 2026 Allogene Therapeutics has announced that it will present the interim futility...
Advertisements
Innovent Showcases Tri-Specific Autoimmune Therapy Data
SAN FRANCISCO & SUZHOU, China, April 9, 2026 Innovent Biologics, Inc. has unveiled preclinical data for its novel tri-specific...
Boehringer Advances Novel Combo Therapy in SCLC Trial
INGELHEIM, Germany, April 9, 2026 Boehringer Ingelheim has announced a strategic clinical trial collaboration with BioNTech to evaluate a...
Oricell Therapeutics Secures $110M for CAR-T Expansion
SHANGHAI, China, April 10, 2026 Oricell Therapeutics Holdings Limited has successfully closed a $110 million pre-IPO financing round, marking...
Immutrin Raises $87M to Advance Amyloidosis Antibody Therapy
CAMBRIDGE, UK, April 8, 2026 Immutrin Ltd has successfully raised £65 million ($87 million) in an oversubscribed Series A...
Phanes Advances Spevatamig to Expansion in BTC Trial
SAN DIEGO, April 7, 2026 Phanes Therapeutics, Inc. has announced the initiation of the dose expansion phase in its...
Advertisement
